When you’re building business rule applications, generic software-development methodologies just aren’t enough.

Agile Business Rule Development (ABRD) is a step-by-step process for developing business rule applications. An iterative methodology, ABRD employs agile software-development values. Rule development is organized as a series of cycles: discovery, analysis, authoring, validation, and deployment. Your team stays on schedule, delivering outstanding business rule applications.

View this free one-hour webinar and learn how to:

• Leverage ABRD as first…

Since its inception in 1996, the JavaOne conference has been the focal point for showcasing the latest and greatest in Java development. ILOG has maintained a presence here for the last decade and this year the focus is on the JViews graphical component suite and its Rich Internet Application (RIA) abilities.

Nicolas Robbe, ILOG’s VP Product Marketing, does a great job of positioning ILOG and BRMS in the SOA space in a recently published video interview by SYS-CON TV from the SOA World West 2007 conference in San Francisco.

On April 14, 2008, in Baltimore, Maryland, Netherlands Railways was awarded the 2008 Franz Edelman Award for Achievement in Operations Research and the Management Sciences. The railway changed their entire timetable, originally created in 1970, to better meet the demands of the current Dutch society.  From another article on the INFORMS site, we learned about the solution that was created, as well as the value of the solution.

Operations researchers at CWI and…

EclipseCon 2008, the fifth annual Eclipse community conference, recently took place in California. ILOG’s Daniel Selman was there, and in his own inimitable style covered the following sessions:

• Maven, Eclipse and OSGi working together
• Implementing a debugger using the DSF framework
• Supporting Multiple Versions of Eclipse
• AMD CodeSleuth
• A Love Supreme?
• Services vs. Extensions
• Cloudsmith
• Eclipse 4.0
• What is new in the Eclipse 3.4 JDT
• Ganymede Packaging
• Babel
• Eclipse and VisualStudio in 2010

…

JRules 6.7 builds on the industry-leading JRules 6 BRMS. There’s more control and flexibility for business users, and expanded support for IT platform infrastructure.

This recorded presentation covers what’s new in JRules 6.7:

• Features
• Benefits
• In-depth product demonstration

Find out why JRules 6.7 is the best solution for managing decision change, complexity, and compliance in your mission-critical business systems.

• View a recorded version of the presentation
• Slides from the presentation

More JRules information:

• JRules product…

In thanking everyone for joining in the conversation at DIALOG 08, Jean-François Abramatic, ILOG’s Chief Product Officer was reminded of the second World Wide Web Conference that he attended in Chicago in 1994.

In the closing session of that event, the attendees were invited to debate the question of whether or not a physical conference was actually needed any more. After all, we now had the Web and email, so…

After a follow-up paper vote on Monday, the most popular presentation selected for Irv Lustig’s last Opti session of the day was “Writing Better Mixed Integer Programming Models.”

I suspect Irv organized a second vote because he wanted to avoid having to give the “Introduction to ILOG CP Optimizer” presentation which actually won the original electronic vote. Whether or not there was any vote-rigging involved, I don’t know, but I…

It was another working lunch today. I sat in on James’ “lunch and learn” session to hear him sharing feedback from the event and discussing best practices with about a dozen or so customers and ILOGers. Below are a few snippets from the informal discussion.

James was blogging the BRMS track throughout the conference and you can find more insights and commentary in his Live from DIALOG series over on his…

In this session, Prasad Saraph from Bayer Healthcare’s Biotech Pharmaceuticals Division provided a fascinating insight into the supply chain issues that Bayer faces in producing one of its key biotech pharmaceutical products.

Kogenate is a leading treatment for hemophilia-A, a genetically transmitted condition that prevents blood clotting and affects 400,000+ people worldwide.

Prasad began with some startling figures: 1,600 employees in 15 manufacturing plants work continuously throughout the year to…